Proliferative glomerulonephritis with monoclonal IgG deposits; an unusual cause of de novo disease in kidney allograft

Sabiha M Hussain, Kalathil K Sureshkumar *

Cited by CrossRef: 6

1- Maan D, Clark B, Bunker M, Arora S. Successful management of proliferative glomerulonephritis with monoclonal immune deposits with combined immunosuppressive therapy. BMJ Case Rep. 2018;11(1):e225205 [Crossref]

2- Frangou E, Varnavidou-Nicolaidou A, Petousis P, Soloukides A, Theophanous E, Savva I, Michael N, Toumasi E, Georgiou D, Stylianou G, Mean R, Anastasiadou N, Athanasiou Y, Zavros M, Kyriacou K, Deltas C, Hadjianastassiou V. Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy. 2019;34(10):1780 [Crossref]

3- Abbas F, El Kossi M, Jin J, Sharma A, Halawa A. De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?. WJT. 2017;7(6):285 [Crossref]

4- Said S, Cosio F, Valeri A, Leung N, Sethi S, Salameh H, Cornell L, Fidler M, Alexander M, Fervenza F, Drosou M, Zhang D, D’Agati V, Nasr S. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft. Kidney International. 2018;94(1):159 [Crossref]

5- Bond T, Mims A, Davis C. An Unusual Kidney Lesion Presenting with Facial Edema, Hematuria, and AKI. Kidney360. 2022;3(6):1118 [Crossref]

6- Sharma P, Julius C, Leal H, Munjal R, Dhillon G, Verma R, Grewal H, Buddhavarapu V, Kashyap R. Proliferative Glomerulonephritis With Monoclonal IgG Deposits: Another Unusual Presentation. 2024; [Crossref]